Fraser Dove International

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐜𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐀𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬𝐖𝐞𝐞𝐤 👇 1️⃣ GE Healthcare has received FDA approval for Flyrcado, a new PET imaging radiotracer designed to improve the detection of coronary artery disease. Its longer half-life and improved diagnostic efficacy make it especially useful for patients with high body mass index (BMI) and women. 📰 https://lnkd.in/eS7DaGCk 2️⃣ Pfizer’s new antibody treatment, Hympavzi (marstacimab-hncq), has received FDA approval as a once-weekly, subcutaneous therapy for hemophilia A and B. It is the first treatment to prevent and reduce bleeding episodes for patients without inhibitors, using a more convenient auto-injector delivery method. 📰 https://lnkd.in/eYMYdFnm 3️⃣ Almirall has finalised the European regulatory process for Jublia (efinaconazole), an antifungal treatment for onychomycosis, a nail infection affecting 5.5% of the global population. This step paves the way for national marketing authorisations across Europe. 📰 https://lnkd.in/eUQTsT8Q 4️⃣ Bayer has submitted an application to the European Medicines Agency (EMA) for approval of its drug elinzanetant, designed to treat moderate to severe vasomotor symptoms (hot flashes) associated with menopause. The non-hormonal drug targets neurokinin-1 and 3 receptors in the brain, offering an alternative to hormone replacement therapies. 📰 https://lnkd.in/eiWM2sNH 5️⃣ UroGen’s new drug application (NDA) for UGN-102, a non-surgical treatment for low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC), has been accepted by the FDA. The treatment uses a sustained-release formulation of mitomycin, designed to increase drug exposure in bladder tissue. 📰 https://lnkd.in/e45wNM7C #RegulatoryActionsAndApprovals | #LifeSciences | #NewsRoundUp

1️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚𝐧 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐥𝐞𝐚𝐝𝐞𝐫 𝐢𝐧 𝐜𝐞𝐥𝐥 𝐚𝐧𝐝 𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐲? 2️⃣ 𝐃𝐨 𝐲𝐨𝐮 𝐡𝐚𝐯𝐞 𝐚 𝐩𝐚𝐬𝐬𝐢𝐨𝐧 𝐟𝐨𝐫 𝐭𝐫𝐚𝐧𝐬𝐢𝐭𝐢𝐨𝐧𝐢𝐧𝐠 𝐨𝐫𝐠𝐚𝐧𝐢𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧𝐭𝐨 𝐜𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬? 3️⃣ 𝐂𝐚𝐧 𝐲𝐨𝐮 𝐬𝐜𝐚𝐥𝐞 𝐮𝐩 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬 𝐰𝐡𝐢𝐥𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 𝐚𝐧𝐝 𝐜𝐮𝐥𝐭𝐮𝐫𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? ✅ A resounding, yes? This role could be for you ✅ Fraser Dove International is partnering exclusively with a leading CGT organisation. Operating in Houston, they are committed to advancing innovative therapies that save patients' lives. As 𝐕𝐢𝐜𝐞 𝐏𝐫𝐞𝐬𝐢𝐝𝐞𝐧𝐭 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬, you will be responsible for overseeing operations, from managing manufacturing facilities to leading scale-up efforts, all while fostering a collaborative, customer-focused culture. 𝐆𝐨𝐭 𝐭𝐡𝐞 𝐤𝐧𝐨𝐰-𝐡𝐨𝐰? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/e-HkUsWn Alternatively, contact Aidan Russell for more information on this and similar opportunities with life science organisations in America, Asia, and Europe. #VicePresidentOperations #LifeSciences #FraserDove #RoleOfTheWeek  

𝐋𝐢𝐟𝐭 𝐔𝐩: 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 – 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐦𝐞𝐧𝐭 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐊𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲    October is Breast Cancer Awareness Month - a time to come together and support each other, and those affected by breast cancer. Join us for an inspiring LinkedIn Live Event designed to raise awareness, foster hope, and empower individuals to take charge of their health.   Join our host Louise Williams (nee Wraight) for a special event featuring leading voices from the world of oncology and personal experience to shine a light on breast cancer, its impact, and the importance of early detection, support, and innovation in care.   Louise will be joined Sheila Ann Mikhail, JD, MBA, Founder & CEO, Board Member at Jurata Thin Film, Catriona Roscoe-Cutting, Regulatory Affairs argenx) and Phuong Khanh (PK) Morrow, MD, FACP, Global Head, Oncology Therapeutic Area Unit at Takeda who will share their insights, stories, and experience within the breast cancer field.    𝐎𝐮𝐫 𝐡𝐨𝐬𝐭𝐬 𝐚𝐧𝐝 𝐞𝐱𝐩𝐞𝐫𝐭𝐬 𝐰𝐢𝐥𝐥 𝐝𝐢𝐬𝐜𝐮𝐬𝐬:   👉 The importance of early detection and how to self-advocate for your health 👉 Innovative treatments and research that are shaping the future of breast cancer care 👉 Emotional and mental resilience: stories of survival and strength  👉 Building a supportive community around those affected by breast cancer 👉 Breast Cancer and Menopause, the call for more research and support for survivors   Breast cancer doesn’t just affect the individual—it touches families, friends, and communities. We lift each other up by raising awareness and sharing our experiences, inspiring hope and action. Whether you're a patient, caregiver, healthcare professional, or advocate, this conversation will equip you with insights, tools, and resources to help make a difference.   Don’t miss this opportunity to learn, connect, and be part of a conversation that could save lives. The event will include a live Q&A, giving you the chance to engage directly with our experts.   #LiftUp | #BreastCancerAwareness | #BreastCancerMonth

“𝐈 𝐟𝐞𝐥𝐭 𝐰𝐞𝐥𝐥 𝐭𝐚𝐤𝐞𝐧 𝐜𝐚𝐫𝐞 𝐨𝐟 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐫𝐨𝐜𝐞𝐬𝐬”. ✅ Showing our customers some TLC ✅ Another enjoyable experience for our candidates 😊 #ExecutiveSearch | #LifeSciences | #FraserDove | #Testimonial

🚨 𝐍𝐞𝐰 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 𝐀𝐥𝐞𝐫𝐭 🚨 Hosted by our Global Head of MedTech, Iain McCulley, we speak to professionals within MedTech, with the aim to add value through insights from inside the industry. With these conversations, we hope to help individuals and organisations overcome some of the biggest challenges in the industry right now. This episode is a part of our 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐒𝐞𝐫𝐢𝐞𝐬, where we aim to have real talk, with real executives, and cut through some of the noise. In this episode we speak to Jeannette Bankes, SVP Group President Global Franchises at Alcon. Jeannette shares her insights into leadership, emotional intelligence, and resilience in navigating the challenges of the MedTech industry. With over 30 years of experience in both Pharma and MedTech, Jeannette offers advice on lifelong learning, the evolving role of emotional intelligence in leadership, and the future of MedTech. Tune in to hear more about: 👉 𝐉𝐞𝐚𝐧𝐧𝐞𝐭𝐭𝐞’𝐬 𝐣𝐨𝐮𝐫𝐧𝐞𝐲 𝐢𝐧 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 👉 𝐄𝐦𝐨𝐭𝐢𝐨𝐧𝐚𝐥 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐚𝐬 𝐚 𝐤𝐞𝐲 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐭𝐫𝐚𝐢𝐭 👉 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐚 𝐝𝐢𝐯𝐞𝐫𝐬𝐞 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐛𝐨𝐚𝐫𝐝 Catch the full episode below 👇 https://lnkd.in/eEFRbaGq #ExecutiveLeadership | #EmotionalIntelligence | #InsideMedTech | #TuneIn

🚀 𝐀𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐎𝐰𝐧𝐞𝐫𝐬! 🚀 Struggling to attract top talent? Our 𝐅𝐑𝐄𝐄 𝐞𝐆𝐮𝐢𝐝𝐞 on candidate attraction is here to help you find, engage, and secure the brightest minds. What you'll learn from our eGuide: 💼 𝐀𝐦𝐩𝐥𝐢𝐟𝐲 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐕𝐨𝐢𝐜𝐞𝐬: Discover strategies to elevate your leadership team's presence, creating an authentic voice behind your hiring strategy. 🔍 𝐎𝐩𝐭𝐢𝐦𝐢𝐬𝐞 𝐘𝐨𝐮𝐫 𝐎𝐧𝐥𝐢𝐧𝐞 𝐅𝐨𝐨𝐭𝐩𝐫𝐢𝐧𝐭: Learn to craft attractive, memorable touchpoints that resonate with senior-level candidates. 📢 𝐌𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐂𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐭 𝐌𝐞𝐬𝐬𝐚𝐠𝐢𝐧𝐠: Ensure your company's values and culture are clearly communicated and resonate with A-Players. 🌟 𝐒𝐡𝐨𝐰𝐜𝐚𝐬𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐂𝐮𝐥𝐭𝐮𝐫𝐞: Highlight what makes your company a unique and desirable workplace, appealing directly to top-tier talent. 💬 𝐋𝐞𝐯𝐞𝐫𝐚𝐠𝐞 𝐒𝐨𝐜𝐢𝐚𝐥 𝐏𝐫𝐨𝐨𝐟: Utilise reviews and testimonials to build trust and credibility, making your company irresistible to top-tier talent. Transform your hiring process and stand out in the competitive life sciences industry today. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐨𝐮𝐫 𝐟𝐫𝐞𝐞 𝐞𝐆𝐮𝐢𝐝𝐞 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐬𝐭𝐚𝐫𝐭 𝐚𝐭𝐭𝐫𝐚𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐭𝐚𝐥𝐞𝐧𝐭 𝐲𝐨𝐮 𝐝𝐞𝐬𝐞𝐫𝐯𝐞! 👇 https://lnkd.in/e4xbbWYd

1️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐚𝐧 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐇𝐑 𝐥𝐞𝐚𝐝𝐞𝐫 𝐥𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐚 𝐡𝐢𝐠𝐡-𝐢𝐦𝐩𝐚𝐜𝐭 𝐢𝐧𝐭𝐞𝐫𝐢𝐦 𝐫𝐨𝐥𝐞? 2️⃣ 𝐃𝐨 𝐲𝐨𝐮 𝐞𝐱𝐜𝐞𝐥 𝐢𝐧 𝐜𝐨𝐚𝐜𝐡𝐢𝐧𝐠 𝐬𝐞𝐧𝐢𝐨𝐫 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐭𝐞𝐚𝐦𝐬 𝐚𝐧𝐝 𝐦𝐚𝐧𝐚𝐠𝐢𝐧𝐠 𝐇𝐑 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐚 𝐟𝐚𝐬𝐭-𝐩𝐚𝐜𝐞𝐝, 𝐦𝐮𝐥𝐭𝐢𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭? 3️⃣ 𝐀𝐫𝐞 𝐲𝐨𝐮 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐬𝐭𝐞𝐩 𝐢𝐧 𝐚𝐧𝐝 𝐦𝐚𝐤𝐞 𝐚𝐧 𝐢𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞? Resonating? This could be your next challenge ✅ Fraser Dove International is partnering exclusively with a leading life sciences organisation. Operating in Brindisi, Italy, they are committed to delivering innovative solutions and industrial excellence. As 𝐈𝐧𝐭𝐞𝐫𝐢𝐦 𝐇𝐮𝐦𝐚𝐧 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, you will be responsible for providing strategic and operational HR support while coaching the site's Executive Leadership Team (ELT) during a period of transition. 𝐅𝐞𝐞𝐥 𝐫𝐢𝐠𝐡𝐭? 𝐀𝐩𝐩𝐥𝐲 𝐭𝐨𝐝𝐚𝐲 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰 👇 https://lnkd.in/efgkvGtF Alternatively, contact Zak Hussain for more information on this and similar opportunities with life science organisations in America, Asia, and Europe. #InterimHumanResourcesDirector #LifeSciences #FraserDove #RoleOfTheWeek

🚨 𝐀𝐭𝐭𝐞𝐧𝐭𝐢𝐨𝐧 𝐋𝐞𝐚𝐝𝐞𝐫𝐬, 𝐃𝐨 𝐘𝐨𝐮𝐫 𝐇𝐨𝐦𝐞𝐰𝐨𝐫𝐤! 🚨 Our Search Consultant, James Bray, offers more valuable advice from his findings. He explains that before accepting a CEO role, it is important to do your due diligence to ensure YOU align with the company, to avoid being blindsided. 👇 Have a read of his full post below 👇

🚨 𝐍𝐞𝐰 𝐄𝐩𝐢𝐬𝐨𝐝𝐞 𝐀𝐥𝐞𝐫𝐭 🚨 Hosted by our Global Head of MedTech, Iain McCulley, we speak to professionals within MedTech, with the aim to add value through insights from inside the industry. With these conversations, we hope to help individuals and organisations overcome some of the biggest challenges in the industry right now. This episode is a part of our Executive Leadership Series, where we aim to have real talk, with real executives, and cut through some of the noise. In this episode we speak to Greg Roche, CEO at Distalmotion. Greg shares insights from his journey through major MedTech organisations like Stryker and Zimmer Biomet and reflects on his transition to leading a smaller, highly focused startup. Topics discussed include the role of robotics in improving surgical care, the increasing importance of AI and data in healthcare, and Greg’s leadership philosophy centred on people and building high-performance cultures. Tune in to hear more about: 👉 𝐆𝐫𝐞𝐠’𝐬 𝐜𝐚𝐫𝐞𝐞𝐫 𝐢𝐧 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 👉 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐞𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐫𝐨𝐛𝐨𝐭𝐢𝐜𝐬 👉 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐜𝐞 𝐨𝐟 𝐢𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲 𝐢𝐧 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 Catch the full episode below 👇 https://lnkd.in/ex4upGMC #ExecutiveLeadership | #IndustryInsights | #InsideMedTech | #TuneIn

👇 𝐓𝐡𝐞𝐬𝐞 𝐀𝐫𝐞 𝐘𝐨𝐮𝐫 𝐓𝐨𝐩 𝟓 𝐍𝐞𝐰𝐬 𝐒𝐭𝐨𝐫𝐢𝐞𝐬 𝐀𝐫𝐨𝐮𝐧𝐝 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐘𝐨𝐮 𝐍𝐞𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐝 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤 👇 1️⃣ Repair Biotechnologies and Genevant Sciences have entered a collaboration to develop mRNA therapies targeting cholesterol build-up in arteries (atherosclerosis). Repair will utilise Genevant's lipid nanoparticle delivery technology to transport cholesterol-degrading mRNA. The deal could result in Genevant receiving up to $107 million per product and tiered royalties. 📰 https://lnkd.in/e8JPSYnv 2️⃣ CSL Seqirus has secured a $121.4 million contract from BARDA to increase the U.S.' stockpile of its MF59 adjuvant, boosting pandemic preparedness for avian influenza. The company will manufacture the adjuvant at its North Carolina facility, expanding reserves to cover 40 million vaccine doses. 📰 https://lnkd.in/eN_Cd6rX 3️⃣ Europlaz, a contract manufacturing specialist, reports a 20% year-on-year sales growth after a £3.5 million investment over three years. The company expanded its capacity by acquiring electric injection moulding machines, upgrading robotics, and enhancing cleanroom facilities, primarily to serve the medical device sector. 📰 https://lnkd.in/eZUamZFy 4️⃣ Mendaera has secured $73 million in Series B funding to advance its handheld robotics platform, designed for needle-based procedures such as biopsies and pain management. The technology combines real-time imaging with robotic guidance to address healthcare provider shortages and increase access to high-quality care. 📰 https://lnkd.in/evQNRhaw 5️⃣ SK pharmteco is investing $260 million to expand its small molecule and peptide production capabilities in Sejong, South Korea. The new facility, expected to be operational by late 2026, will include eight production lines, supporting the increasing demand for peptides and small molecules used in innovative therapies. 📰 https://lnkd.in/eQ63p8j2 #FinancialDevelopments | #LifeSciences | #NewsRoundUp